Abstract
A 62-year-old woman had chronic cavitary pulmonary sporotrichosis refractory to medical management over an 8-year period. She was treated with oral itraconazole and had an apparent microbiologic and clinical response; however, the patient succumbed to progressive pulmonary hypertension. The early use of oral itraconazole for treatment of pulmonary sporotrichosis is advocated.
MeSH terms
-
Amphotericin B / therapeutic use
-
Antifungal Agents / administration & dosage
-
Antifungal Agents / therapeutic use*
-
Female
-
Humans
-
Itraconazole
-
Ketoconazole / administration & dosage
-
Ketoconazole / analogs & derivatives*
-
Ketoconazole / therapeutic use
-
Lung Diseases, Fungal / drug therapy*
-
Middle Aged
-
Potassium Iodide / therapeutic use
-
Sporotrichosis / drug therapy*
Substances
-
Antifungal Agents
-
Potassium Iodide
-
Itraconazole
-
Amphotericin B
-
Ketoconazole